Leveragen, Inc.
PrivateLast Round
Strategic
Jul 25, 2025
Company Overview
Leveragen, Inc. operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. It was founded in 2017.
Leveragen, Inc. is a biotechnology company that provides customized genetic modeling services and proprietary antibody discovery platforms for pharmaceutical and biotechnology partners.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leveragen, Inc. Comparables
Compare Leveragen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 85% | |
| Alloy Therapeutics | 79% | |
| KisoJi Biotechnology | 78% |
For institutional investors. Book with your work email.
Leveragen, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors increased 54% MoM.
- Jan 31, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
Leveragen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leveragen, Inc.'s valuation, stock price, and market status.
Is Leveragen, Inc. a public or private company?
Leveragen, Inc. is a private company.
What is the current stock price of Leveragen, Inc.?
Leveragen, Inc. is a private company, so its shares have no public market price. Caplight tracks Leveragen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leveragen, Inc. worth (valuation)?
Valuation information for Leveragen, Inc. is not publicly available.
Can I buy Leveragen, Inc. stock?
Leveragen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leveragen, Inc.'s last funding round?
Leveragen, Inc.'s most recent funding round was Strategic on July 25, 2025.
Who are the main investors in Leveragen, Inc.?
Investor information for Leveragen, Inc. is not publicly disclosed.
Will Leveragen, Inc. IPO soon?
No public IPO plans have been announced for Leveragen, Inc..
How can I track Leveragen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Leveragen, Inc.'s shares on secondary markets.